ArticleThe pharmacogenomics journal2021

Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore.

Ji Heon Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.